Kim Kyoung-Tae, Cho Dae-Chul, Sung Joo-Kyung, Kim Young-Baeg, Kang Hyun, Song Kwang-Sup, Choi Geun-Joo
Department of Neurosurgery, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 700-720, Korea.
Department of Neurosurgery, College of Medicine, Chung-Ang University Hospital, 224-1 Heukseok-dong, Dongjak-gu, Seoul 156-755, Korea.
Spine J. 2014 Aug 1;14(8):1559-66. doi: 10.1016/j.spinee.2013.09.031. Epub 2013 Nov 8.
Analgesic effect of lidocaine infusion on postoperative pain.
The aim of this study was to evaluate the analgesic effect of lidocaine infusion on postoperative pain after lumbar microdiscectomy.
This study used a prospective, randomized, double-blinded, and placebo-controlled clinical trial.
Fifty-one patients participated in this randomized, double-blinded study.
The primary outcome was the visual analog scale (VAS) (0-100 mm) pain score at 4 hours after surgery. The secondary outcomes were the VAS pain score at 2, 8, 12, 24, and 48 hours after surgery, the frequency with which patients pushed the button (FPB) of the patient-controlled analgesia system, and the fentanyl consumption at 2, 4, 8, 12, 24, and 48 hours after surgery. Other outcomes were satisfaction scores regarding pain control and the overall recovery process, incidence of postoperative nausea and vomiting (PONV), and length of hospital stay (HS).
Preoperatively and throughout the surgery, Group L received intravenous lidocaine infusion (a 1.5-mg/kg bolus followed by a 2-mg/kg/h infusion until the end of the surgical procedure) and Group C received normal saline infusion as a placebo.
The VAS scores and fentanyl consumption were significantly lower in Group L compared with Group C except at 48 h after surgery (p<.05). Total fentanyl consumption, total FPB, length of HS, and satisfaction scores were also significantly lower in Group L compared with Group C (p<.05).
Intraoperative systemic infusion of lidocaine decreases pain perception during microdiscectomy, thus reducing the consumption of opioid and the severity of postoperative pain. This effect contributes to reduce the length of HS.
利多卡因输注对术后疼痛的镇痛效果。
本研究旨在评估利多卡因输注对腰椎间盘显微切除术术后疼痛的镇痛效果。
本研究采用前瞻性、随机、双盲、安慰剂对照临床试验。
51名患者参与了这项随机双盲研究。
主要观察指标为术后4小时的视觉模拟评分(VAS)(0 - 100mm)疼痛评分。次要观察指标为术后2、8、12、24和48小时的VAS疼痛评分、患者自控镇痛系统的患者按压按钮频率(FPB)以及术后2、4、8、12、24和48小时的芬太尼消耗量。其他观察指标为疼痛控制和整体恢复过程的满意度评分、术后恶心呕吐(PONV)的发生率以及住院时间(HS)。
术前及整个手术过程中,L组接受静脉输注利多卡因(先静脉推注1.5mg/kg,然后以2mg/kg/h的速度输注直至手术结束),C组接受生理盐水输注作为安慰剂。
除术后48小时外,L组的VAS评分和芬太尼消耗量均显著低于C组(p<0.05)。L组的芬太尼总消耗量、FPB总数、HS长度和满意度评分也显著低于C组(p<0.05)。
术中全身输注利多卡因可降低显微椎间盘切除术期间的疼痛感知,从而减少阿片类药物的消耗量和术后疼痛的严重程度。这种效果有助于缩短HS长度。